ID   Sp2/0-Ag14-K13
AC   CVCL_C4CP
SY   Sp2/0-Ag14-k13
DR   Wikidata; Q116050529
RX   PubMed=1279746;
RX   PubMed=8150984;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
RX   PubMed=1279746; DOI=10.1016/0090-6980(92)90006-f;
RA   Hishinuma T., Shimomura K., Nishikawa M., Ohyama Y., Ishibashi M.,
RA   Mizugaki M.;
RT   "Separation and concentration of delta 17-6-keto-PGF1 alpha using
RT   monoclonal antibody to omega 3-olefin structure of trienoic
RT   prostanoids.";
RL   Prostaglandins 44:329-338(1992).
//
RX   PubMed=8150984; DOI=10.1080/15321819408009569;
RA   Mizugaki M., Itoh K., Hayasaka M., Ishiwata S., Nozaki S., Nagata N.,
RA   Hanadate K., Ishida N.;
RT   "Monoclonal antibody-based enzyme-linked immunosorbent assay for
RT   glycyrrhizin and its aglycon, glycyrrhetic acid.";
RL   J. Immunoassay 15:21-34(1994).
//